Table 1—

Baseline characteristics

	IC	UC	p-values
Subjects	65	90
Sociodemographics
Age yrs	70±9	72±9	0.09
Sex (females)	15 (23)	11 (12)	0.64
Education less than primary	16 (25)	20 (22)	0.85
Annual income <\#8364;6000	7 (13)	16 (24)	0.16
Clinical and functional profile
Length baseline hospitalisation	8.5±5.5	7.8±4.2	0.65
MRC dyspnoea scale	3.5±1.3	3.5±1.2	0.84
BMI kg·m^-2	26.4±5.1	26.1±5.4	0.71
FVC % pred	64±21	63±18	0.79
FEV₁ % pred	43±20	41±15	0.89
FEV₁/FVC %	48±18	48±17	0.95
P_a,O₂mmHg	64±11	64±14	0.65
P_a,CO₂mmHg	44±7	44±7	0.87
Comorbidities	1.9±1.4	1.8±1.5	0.74
Hospital respiratory admissions previous yr	1.0±1.3	0.6±1.2	0.05
SGRQ total score	57±18	59±18	0.46
Euroqol analogue visual scale^#	47.8±18.1	47.4±18.5	0.87
Anxiety and depression Goldberg score	8.5±5.6	8.2±5.9	0.71
Apgar score^¶	7.6±4.2	6.3±2.9	0.18
Regular COPD treatment
LTOT	16 (25)	21 (23)	0.85
Influenza vaccination	36 (56)	68 (78)	0.01
Pneumococcal vaccination	19 (36)	41 (53)	0.07
Home rehabilitation	17 (26)	20 (22)	0.57
Self-management
Active smokers	21 (32)	19 (21)	0.14
Knowledge-name and cause of the disease	45 (69)	58 (65)	0.61
Poor adherence to inhalers	14 (23)	23 (28)	0.56
Regular physical activity	56 (86)	82 (91)	0.43
Knowledge alarm symptoms and drugs	44 (68)	66 (73)	0.48

Data are presented as n, mean±sd or n (%). IC: integrated care; UC: usual care; MRC: Medical Research Council scale for scoring dyspnoea; BMI; body mass index; FVC: forced vital capacity; % pred: % predicted; FEV₁: forced expiratory volume in one second; FEV₁/FVC ratio: expressed as actual value; P_a,O₂: arterial oxygen tension; P_a,CO₂: carbon dioxide arterial tension; SGRQ: Saint George’s Respiratory Questionnaire to assess health-related quality of life; Apgar: adaptability, partnership, growth, affection and resolve; COPD: chronic obstructive pulmonary disease; LTOT: long-term oxygen therapy. ^#: instrument to assess health-related quality of life; ^¶: to assess family functionality. 1 mmHg = 0.133 kPa.